Early childhood trauma, substance use and complex concurrent disorders among adolescents.
Journal
Current opinion in psychiatry
ISSN: 1473-6578
Titre abrégé: Curr Opin Psychiatry
Pays: United States
ID NLM: 8809880
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
pubmed:
17
5
2021
medline:
10
9
2021
entrez:
16
5
2021
Statut:
ppublish
Résumé
To highlight the interdependence between early childhood trauma, substance use and complex concurrent disorders among adolescents and discuss the delayed response and gaps in the healthcare system. High-risk behavior such as suicidality, self-harm and hazardous substance use including overdose and the use of psychotropic substances for self-medication of mental health challenges is a growing concern. These symptoms are often related to early childhood trauma, substance use and complex concurrent disorders. Most countries do not have a youth mental healthcare system, there are no specific guidelines and only few programs addressing high-risk substance use are in place. In addition to the significance of traumatic experience for high-risk substance use and addiction, most parts of the system of care ignore the trauma aspect in treatment of substance use and focus on abstinence. There are hardly any early intervention programs, broader prevention strategies or evidence-based or target-group-oriented treatment offers.
Identifiants
pubmed: 33993169
doi: 10.1097/YCO.0000000000000718
pii: 00001504-202107000-00011
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
393-399Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Kingston S, Raghavan C. The relationship of sexual abuse, early initiation of substance use, and adolescent trauma to PTSD. J Trauma Stress 2009; 22:65–68.
Deykin EY, Buka SL. Prevalence and risk factors for posttraumatic stress disorder among chemically dependent adolescents. Am J Psychiatry 1997; 154:752–757.
Funk RR, Mcdermeit M, Godley SH, Adams L. maltreatment issues by level of adolescent substance abuse treatment: the extent of the problem at intake and relationship to early outcomes. Child Maltreat 2003; 8:36–45.
Arnow BA. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry 2004; 65: (Suppl 12): 10–15.
Enoch MA. The influence of gene-environment interactions on the development of alcoholism and drug dependence. Curr Psychiatry Rep 2012; 14:150–158.
Pilowsky DJ, Keyes KM, Hasin DS. Adverse childhood events and lifetime alcohol dependence. Am J Public Health 2009; 99:258–263.
Schütz C, Choi F, Jae Song M, et al. Living with dual diagnosis and homelessness: Marginalized within a marginalized group. J Dual Diagn 2019; 15:88–94.
Hadland SE, Yule AM, Levy SJ, et al. Evidence-based treatment of young adults with substance use disorders. Pediatrics 2021; 147: (Suppl 2): S204–S214.
Cloutier RL, Marshaall R. A dangerous pandemic pair: covid 19 and adolescent mental health emergencies. Am J Emerg Med 2020; [Epub ahead of print].
Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. Am J Prevent Med 1998; 14:245–258.
Dube SR, Felitti VJ, Dong M, et al. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the Adverse Childhood Experiences Study. Pediatrics 2003; 111:564–572.
Dube SR, Anda RF, Felitti VJ, et al. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA 2001; 286:3089–3096.
Finkelhor D, Turner HA, Hamby S. Let's prevent peer victimization, not just bullying. Child Abuse Negl 2012; 36:271–274.
Merrick MT, Ford DC, Ports KA, Guinn AS. Prevalence of adverse childhood experiences from the 2011-2014 Behavioral Risk Factor Surveillance System in 23 States. JAMA Pediatr 2018; 172:1038–1044.
Farrugia PL, Mills KL, Barrett E, et al. Childhood trauma among individuals with co-morbid substance use and posttraumatic stress disorder. Mental Health Subst Use 2011; 4:314–326.
Zhang S, Lin X, Liu J, et al. Prevalence of childhood trauma measured by the short form of the Childhood Trauma Questionnaire in people with substance use disorder: A meta-analysis. Psychiatry Res 2020; 294:113524.
Stoltenborgh M, Bakermans-Kranenburg MJ, Alink LRA, van IJzendoorn MH. The prevalence of child maltreatment across the globe: review of a series of meta-analyses: prevalence of child maltreatment across the globe. Child Abuse Rev 2015; 24:37–50.
Chanchlani N, Buchanan F, Gill PJ. Addressing the indirect effects of COVID-19 on the health of children and young people. CMAJ 2020; 192:E921–E927.
Giordano GN, Ohlsson H, Kendler KS, et al. Unexpected adverse childhood experiences and subsequent drug use disorder: a Swedish population study (1995-2011): childhood trauma, drug use disorder. Addiction 2014; 109:1119–1127.
Coyer SM. Women in recovery discuss parenting while addicted to cocaine. MCN Am J Matern Child Nurs 2003; 28:45–49.
Teixeira CAB, Lasiuk G, Barton S, et al. An exploration of addiction in adults experiencing early-life stress: a metasynthesis. Rev Lat Am Enfermagem 2017; 25:e2939.
Bowles MA, DeHart D, Webb JR. Family influences on female offenders’ substance use: the role of adverse childhood events among incarcerated women. J Fam Viol 2012; 27:681–686.
Lander L, Howsare J, Byrne M. The impact of substance use disorders on families and children: from theory to practice. Soc Work Public Health 2013; 28:194–205.
Levy S. Youth and the opioid epidemic. Pediatrics 2019; 143:e20182752.
Hunt GE, Malhi GS, Lai HMX, Cleary M. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis. J Affect Disord 2020; 266:288–304.
Werlen L, Puhan MA, Landolt MA, Mohler-Kuo M. Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults. BMC Public Health 2020; 20:1470.
Brewer AG, Davis MM, Sheehan K, Feinglass J. Sociodemographic characteristics associated with hospitalizations for anxiety and depression among youth in Illinois. Acad Pediatr 2020; 20:1133–1139.
CIHI. Hospital stays for harm caused by substance use among youth age 10 to 24. 2019.
Carmona J, Maxwell JC, Park J-Y, Wu L-T. Prevalence and health characteristics of prescription opioid use, misuse, and use disorders among U.S. adolescents. J Adolesc Health 2020; 66:536–544.
Alinsky RH, Zima BT, Rodean J, et al. Receipt of addiction treatment after opioid overdose among medicaid-enrolled adolescents and young adults. JAMA Pediatr 2020; 174:e195183.
Adams SH, Knopf DK, Park MJ. Prevalence and treatment of mental health and substance use problems in the early emerging adult years in the United States: findings from the 2010 National Survey on Drug Use and Health. Emerg Adulthood 2014; 2:163–172.
Wiktorowicz M, Abdulle A, Di Pierdomenico K, Boamah SA. Models of concurrent disorder service: policy, coordination, and access to care. Front Psychiatry 2019; 10:61.
British Columbia. Coroners Service News, Updates and Reports - Province of British Columbia [Internet]. Province of British Columbia [cited 5 February 2021]. Available at: https://www2.gov.bc.ca/gov/content/life-events/death/coroners-service/news-and-updates . [Accessed 6 May 2021]
Adams ZW, McCauley JL, Back SE, et al. Clinician perspectives on treating adolescents with co-occurring post-traumatic stress disorder, substance use, and other problems. J Child Adolesc Subst Abuse 2016; 25:575–583.
Barrett EL, Adams ZW, Kelly EV, et al. Service provider perspectives on treating adolescents with co-occurring PTSD and substance use: challenges and rewards. ADD 2019; 12:173–183.
National Child Traumatic Stress Network (NCTSN), and United States of America. “Understanding Links Between Adolescent Trauma and Substance Abuse: A Toolkit for Providers.” (2008).
Correll CU, Galling B, Pawar A, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 2018; 75:555–565.
Charlson FJ, Ferrari AJ, Santomauro DF, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study. Schizophrenia Bull 2018; 44:1195–1203.
Greenwald, Glenn. “Drug decriminalization in Portugal: lessons for creating fair and successful drug policies.” Cato Institute Whitepaper Series (2009). [Accessed 6 May 2021]
Christie GIG, Cheetham A, Lubman DI. Interventions for alcohol and drug use disorders in young people: 10 key evidence-based approaches to inform service delivery. Curr Addict Rep 2020; 7:464–474.
Wittchen H-U, Behrendt S, Höfler M, et al. What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res 2008; 17: (Suppl 1): S16–S29.
Helsdirektoratet. National guideline for health promotion and preventive work in the child and youth health centres and school health service, 0-20 years [Internet]. Available at: https://www.helsedirektoratet.no/retningslinjer/helsestasjons-og-skolehelsetjenesten/dokumenter-helsestasjons-og-skolehelsetjenesten/National%20guideline%20for%20health%20promotion%20and%20preventive%20work%20in%20the%20child%20.pdf/_/attachment/inline/854312bb-434e-4aab-b7eb-125d558eb434:a0aaa3fec5902792de20d18abfddeee13bd377c8/National%20guideline%20for%20health%20promotion%20and%20preventive%20work%20in%20the%20child%20.pdf . [Accessed 6 May 2021]
Rehbein F, Weber J, Christine Bergmann M, et al. Reichweite von Suchtprävention aus der Perspektive jugendlicher Endadressaten. SUCHT 2019; 65:48–59.
Thornton LK, Chapman C, Leidl D, et al. Climate schools plus: an online, combined student and parent, universal drug prevention program. Internet Interv 2018; 12:36–45.
Hadland SE, Bagley SM, Rodean J, et al. Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatr 2018; 172:1029–1037.
Wagner V, Bertrand K, Flores-Aranda J, et al. Initiation of addiction treatment and access to services: young adults’ accounts of their help-seeking experiences. Qual Health Res 2017; 27:1614–1627.
Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults’ opioid use trajectories: from nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addictive Behaviors 2018; 86:118–123.
Hadland SE, Wharam JF, Schuster MA, et al. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014. JAMA Pediatr 2017; 171:747–755.
McGorry PD, Tanti C, Stokes R, et al. Headspace: Australia's National Youth Mental Health Foundation — where young minds come first. Med J Aust 2007; 187 (S7):S68–S70.
Müller C, Trabi T. „Österreichisches Modell“ der Opioidsubstitution bei Minderjährigen: Modell der mehrdimensionalen Behandlungsstrategien. Monatsschr Kinderheilkd 2019; 167:109–116.
Dass-Brailsford P, Myrick AC. Psychological trauma and substance abuse: the need for an integrated approach. Trauma Violence Abuse 2010; 11:202–213.
Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008; 34:123–138.
Österreichische Gesellschaft für arzneimittelgestützte Behandlung von Suchtkrankheit, (ÖGABS), Österreichische Gesellschaft für Allgemein- und Familienmedizin (ÖGAM), Österreichische Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und, Psychotherapie (ÖGKJP), Österreichische Gesellschaft für Psychiatrie und Psychotherapie (ÖGPP). Leitlinie - Qualitätsstandards für die Opioidsubstitutinstherapie. 2017 (1. Auflage).
Kumar N, Stowe ZN, Han X, Mancino MJ. Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program: impact of early trauma on buprenorphine retention. Am J Addict 2016; 25:542–548.
ASSIST - Sektorenunabhängige Beratungskoordination mittels Online-Assessment bei substanzbezogenen Störungen [Internet]. [cited 5 February 2021]. Available at: https://innovationsfonds.g-ba.de/projekte/neue-versorgungsformen/kompass-sektorenunabhaengige-behandlungskoordination-mittels-online-assessment-fuer-patientinnen-und-patienten-mit-substanzbezogenen-stoerungen.365 . [Accessed 6 May 2021]